WGRX
Wellgistics Health, Inc.
Medical - Distribution
Market Cap$8M
5Y Perf.-96.9%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
WGRX vs OMI
Revenue, margins, valuation, and 5-year total return — side by side.
OMI
Owens & Minor, Inc.
Medical - Distribution
Market Cap$171M
5Y Perf.-76.9%
WGRX vs OMI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | WGRX | OMI |
|---|---|---|
| Industry | Medical - Distribution | Medical - Distribution |
| Market Cap | $8M | $171M |
| Revenue (TTM) | $6M | $2.76B |
| Net Income (TTM) | $-73M | $-1.10B |
| Gross Margin | 4.1% | — |
| Operating Margin | -12.1% | 1.0% |
| Forward P/E | — | 2.3x |
| Total Debt | $25M | $320M |
| Cash & Equiv. | $1M | $282M |
WGRX vs OMI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
WGRX
OMI
| Stock | Feb 25 | May 26 | Return |
|---|---|---|---|
| Wellgistics Health,… (WGRX) | 100 | 3.1 | -96.9% |
| Owens & Minor, Inc. (OMI) | 100 | 23.1 | -76.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WGRX vs OMI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: OMI leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Wellgistics Health, Inc. is the stronger pick specifically for capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
WGRX
Wellgistics Health, Inc.
The Income Pick
WGRX is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 0.99
- Lower volatility, beta 0.99, current ratio 0.40x
- Beta 0.99, current ratio 0.40x
Best for: income & stability and sleep-well-at-night
OMI
Owens & Minor, Inc.
The Growth Play
OMI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth -74.2%, EPS growth -201.1%, 3Y rev CAGR -34.8%
- -86.2% 10Y total return vs WGRX's -97.8%
- -74.2% revenue growth vs WGRX's -91.8%
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | OMI | -74.2% revenue growth vs WGRX's -91.8% |
| Quality / Margins | OMI | -39.8% margin vs WGRX's -13.0% |
| Stability / Safety | WGRX | Beta 0.99 vs OMI's 1.45 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | OMI | -68.0% vs WGRX's -97.2% |
| Efficiency (ROA) | OMI | -44.9% ROA vs WGRX's -138.4%, ROIC 1.8% vs -32.2% |
WGRX vs OMI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
WGRX vs OMI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLOMILAGGINGWGRX
WGRXWellgistics Health, I…
0leads
OMIOwens & Minor, Inc.
2leads
6 Total Categories
CATEGORYLEADERvs WGRXMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
OMI4/5
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
OMI6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
OMI leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
OMI is the larger business by revenue, generating $2.8B annually — 491.6x WGRX's $6M. Profitability is closely matched — net margins range from -39.8% (OMI) to -13.0% (WGRX). On growth, WGRX holds the edge at -80.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | WGRXWellgistics Healt… | OMIOwens & Minor, In… |
|---|---|---|
| RevenueTrailing 12 months | $6M | $2.8B |
| EBITDAEarnings before interest/tax | -$65M | $277M |
| Net IncomeAfter-tax profit | -$73M | -$1.1B |
| Free Cash FlowCash after capex | -$7M | -$353M |
| Gross MarginGross profit ÷ Revenue | +4.1% | — |
| Operating MarginEBIT ÷ Revenue | -12.1% | +1.0% |
| Net MarginNet income ÷ Revenue | -13.0% | -39.8% |
| FCF MarginFCF ÷ Revenue | -130.5% | -12.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -80.9% | -146.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -11.8% | +4.5% |
OMI leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
Evenly matched — WGRX and OMI each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | WGRXWellgistics Healt… | OMIOwens & Minor, In… |
|---|---|---|
| Market CapShares × price | $8M | $171M |
| Enterprise ValueMkt cap + debt − cash | $32M | $209M |
| Trailing P/EPrice ÷ TTM EPS | -0.65x | -0.16x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 2.31x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 1.70x |
| Price / SalesMarket cap ÷ Revenue | 0.42x | 0.06x |
| Price / BookPrice ÷ Book value/share | 0.65x | — |
| Price / FCFMarket cap ÷ FCF | — | — |
Evenly matched — WGRX and OMI each lead in 1 of 2 comparable metrics.
Profitability & Efficiency
Evenly matched — WGRX and OMI each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
WGRX delivers a -10.8% return on equity — every $100 of shareholder capital generates $-11 in annual profit, vs $-21 for OMI. On the Piotroski fundamental quality scale (0–9), WGRX scores 6/9 vs OMI's 2/9, reflecting solid financial health.
| Metric | WGRXWellgistics Healt… | OMIOwens & Minor, In… |
|---|---|---|
| ROE (TTM)Return on equity | -10.8% | -21.1% |
| ROA (TTM)Return on assets | -138.4% | -44.9% |
| ROICReturn on invested capital | -32.2% | +1.8% |
| ROCEReturn on capital employed | -73.4% | +1.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 2 |
| Debt / EquityFinancial leverage | 3.73x | — |
| Net DebtTotal debt minus cash | $24M | $38M |
| Cash & Equiv.Liquid assets | $1M | $282M |
| Total DebtShort + long-term debt | $25M | $320M |
| Interest CoverageEBIT ÷ Interest expense | -10.95x | -0.12x |
Evenly matched — WGRX and OMI each lead in 4 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
OMI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OMI five years ago would be worth $672 today (with dividends reinvested), compared to $221 for WGRX. Over the past 12 months, OMI leads with a -68.0% total return vs WGRX's -97.2%. The 3-year compound annual growth rate (CAGR) favors OMI at -49.9% vs WGRX's -71.9% — a key indicator of consistent wealth creation.
| Metric | WGRXWellgistics Healt… | OMIOwens & Minor, In… |
|---|---|---|
| YTD ReturnYear-to-date | -80.6% | -3.4% |
| 1-Year ReturnPast 12 months | -97.2% | -68.0% |
| 3-Year ReturnCumulative with dividends | -97.8% | -87.4% |
| 5-Year ReturnCumulative with dividends | -97.8% | -93.3% |
| 10-Year ReturnCumulative with dividends | -97.8% | -86.2% |
| CAGR (3Y)Annualised 3-year return | -71.9% | -49.9% |
OMI leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — WGRX and OMI each lead in 1 of 2 comparable metrics.
Risk & Volatility
WGRX is the less volatile stock with a 0.99 beta — it tends to amplify market swings less than OMI's 1.45 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OMI currently trades 23.5% from its 52-week high vs WGRX's 1.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | WGRXWellgistics Healt… | OMIOwens & Minor, In… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.99x | 1.45x |
| 52-Week HighHighest price in past year | $7.04 | $9.55 |
| 52-Week LowLowest price in past year | $0.08 | $1.84 |
| % of 52W HighCurrent price vs 52-week peak | +1.2% | +23.5% |
| RSI (14)Momentum oscillator 0–100 | 29.1 | 46.5 |
| Avg Volume (50D)Average daily shares traded | 13.8M | 690K |
Evenly matched — WGRX and OMI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | WGRXWellgistics Healt… | OMIOwens & Minor, In… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $15.60 |
| # AnalystsCovering analysts | — | 10 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
OMI leads in 2 of 6 categories — strongest in Income & Cash Flow and Total Returns. 3 categories are tied.
Best OverallOwens & Minor, Inc. (OMI)Leads 2 of 6 categories
Loading custom metrics...
WGRX vs OMI: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is WGRX or OMI a better buy right now?
Analysts rate Owens & Minor, Inc.
(OMI) a "Hold" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — WGRX or OMI?
Over the past 5 years, Owens & Minor, Inc.
(OMI) delivered a total return of -93. 3%, compared to -97. 8% for Wellgistics Health, Inc. (WGRX). Over 10 years, the gap is even starker: OMI returned -86. 2% versus WGRX's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — WGRX or OMI?
By beta (market sensitivity over 5 years), Wellgistics Health, Inc.
(WGRX) is the lower-risk stock at 0. 99β versus Owens & Minor, Inc. 's 1. 45β — meaning OMI is approximately 47% more volatile than WGRX relative to the S&P 500.
04Which is growing faster — WGRX or OMI?
On earnings-per-share growth, the picture is similar: Wellgistics Health, Inc.
grew EPS -116. 7% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — WGRX or OMI?
Wellgistics Health, Inc.
(WGRX) is the more profitable company, earning -37. 8% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps -37. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OMI leads at 1. 0% versus -33. 9% for WGRX. At the gross margin level — before operating expenses — WGRX leads at 9. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — WGRX or OMI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is WGRX or OMI better for a retirement portfolio?
For long-horizon retirement investors, Wellgistics Health, Inc.
(WGRX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 99)). Both have compounded well over 10 years (WGRX: -97. 8%, OMI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between WGRX and OMI?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(WGRX: -80.9% · OMI: -146.3%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.